Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
DEA continues countrywide fentanyl awareness summits with event in Alhambra DEA continues countrywide fentanyl awareness summits with event in Alhambra ...
Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the ...
Mark Zuckerberg, chief executive officer of Meta Platforms Inc., during an interview on "The Circuit with Emily Chang" at Meta ...
Before co-founding biotech startup Inceptive, Jakob Uszkoreit had an idea that would eventually make generative artificial intelligence possible. As a ...
Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee on Financial Services and General ...
Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a ...
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in ...
Front lines of America's fentanyl crisis On the front lines of America's fentanyl crisis 04:24 About one in three Americans ...
